Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.

Investing.com -- Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial ...

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts. Struggling ...

Price discrepancies for the same medical procedures show how unfair insurance practices erode trust, leaving patients ...

Yet the product had been operating in a legal gray area while it underwent official FDA review about its health effects and uptake among you ng users. To that latter point, the FDA found that, so far, ...

It's a new year, and weight loss is tops for many among goals for 2025. Here are 10 tips to avoid falling for a "quick" ...

The victim, Rajendra Singh, a resident of Urban Estate Phase-II in Durgi, lodged a complaint with the cybercrime police, detailing the elaborate scam ... a new "smart health card" for retired ...